fluvoxamine and 1-3-dipropyl-8-cyclopentylxanthine

fluvoxamine has been researched along with 1-3-dipropyl-8-cyclopentylxanthine* in 1 studies

Other Studies

1 other study(ies) available for fluvoxamine and 1-3-dipropyl-8-cyclopentylxanthine

ArticleYear
A preliminary study on the interaction of fluvoxamine and adenosine receptor on isolated Guinea-pig atria.
    The International journal of neuroscience, 2006, Volume: 116, Issue:12

    Fluvoxamine (FLV), a selective serotonin reuptake inhibitor (SSRI) antidepressant, caused a dose-dependent decrease in rate and contractile force of the isolated guinea-pig atria. These effects significantly blocked by DPCPX, a specific A(1) receptor antagonist. Theophylline, an A(1)/A(2A) receptor antagonist, also prevented the inotropic and chronotropic effect of FLV. The atrium was dissected out and suspended in modified Krebs solution under physiologic conditions. Drug was added to the solution. The changes in rate and contractions were measured using a physiograph. The data indicate that DPCPX and theophylline prevent the inotropic and chronotropic effects of FLV on atria, but these effects were not prevented by atropine and DMPX, an A(2) receptor antagonist. Adenosine A(1) receptor blockade attenuates FLV effects in isolated guinea-pig atria.

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Atropine; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluvoxamine; Guinea Pigs; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pilot Projects; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Theophylline; Xanthines

2006